During the past decade, TriWest Research Associates, LLC conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 53 clinical trials were completed, i.e. on average, 91.4% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 36 clinical trials were completed. i.e. 276.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "TriWest Research Associates, LLC" #1 sponsor was "Pfizer" with 7 trials, followed by "Allergan" with 6 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored, "Centrexion Therapeutics" with 4 trials sponsored and "Eli Lilly and Company" with 4 trials sponsored. Other sponsors include 50 different institutions and companies that sponsored additional 46 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "TriWest Research Associates, LLC" #1 collaborator was "Quintiles, Inc." with 3 trials as a collaborator, "OCT Clinical Trials" with 2 trials as a collaborator, "Teva Pharmaceutical Industries, Ltd." with 2 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "TriWest Research Associates, LLC" are "Rheumatoid Arthritis" (12 trials), "Osteoarthritis, Knee" (7 trials), "Gastroparesis" (6 trials), "Systemic Lupus Erythematosus" (6 trials) and "Osteoarthritis" (5 trials). Many other conditions were trialed in "TriWest Research Associates, LLC" in a lesser frequency.

Most popular intervention types in "TriWest Research Associates, LLC" are "Drug" (69 trials), "Biological" (9 trials), "Other" (8 trials), "Device" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (42 trials), "Relamorelin" (4 trials), "CNTX-4975" (3 trials), "BI 695501" (2 trials) and "Baricitinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "TriWest Research Associates, LLC" are 78 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "TriWest Research Associates, LLC". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in TriWest Research Associates, LLC, undefined suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in TriWest Research Associates, LLC, 2 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".